Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK InhibitionOlga K. Mirzoeva, W. Michael Korn, Doris R. Siwak et al.|Cancer Research|2009Cited by 390
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancerHayley Donnella, Sourav Bandyopadhyay, James T. Webber et al.|Nature Chemical Biology|2018Cited by 92